Anti-tumor effects of an ID antagonist with no observed acquired resistance

Paulina M. Wojnarowicz(Memorial Sloan Kettering Cancer Center), Robert Benezra(Memorial Sloan Kettering Cancer Center)
npj Breast Cancer
May 24, 2021
Cited by 28


Related Papers